Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Clin Cancer Res. 2017 Apr 1;23(7):1647–1655. doi: 10.1158/1078-0432.CCR-16-3275

Figure 4. Putative therapeutic interventions directly or indirectly target super enhancers and epigenetic networks in multiple cell lineages in pancreatic regenerative program.

Figure 4

A range of novel drugs (shown in red) directly or indirectly disrupt super enhancers by targeting epigenetic modifiers that integrate the regenerative super enhancer-driven sub-programs in each of the epithelial and stromal compartments that participate in the hacked repair program.